Ponvory Europska Unija - danski - EMA (European Medicines Agency)

ponvory

janssen-cilag international n.v.    - ponesimod - multipel sklerose, recidiverende-remitterende - immunosuppressiva - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

Fingolimod Mylan Europska Unija - danski - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod hydrochlorid - multipel sklerose, recidiverende-remitterende - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1)orpatients med hurtigt udviklende alvorlige relapserende remitterende multipel sklerose, der er defineret ved 2 eller flere invaliderende tilbagefald i et år, og med 1 eller flere gadolinium øge læsioner på hjernen mr-scanning eller en betydelig stigning i t2 læsion belastning i forhold til en tidligere de seneste mr -.

Clobex 500 mikrogram/g shampoo Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

clobex 500 mikrogram/g shampoo

nordic prime aps - clobetasolpropionat - shampoo - 500 mikrogram/g

Fingolimod Mylan Europska Unija - danski - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - fingolimod hydrochlorid - multipel sklerose, recidiverende-remitterende - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 og 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Viclonor 100 mg depottabletter Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

viclonor 100 mg depottabletter

nordic prime aps - diclofenacnatrium - depottabletter - 100 mg

Viclonor 75 mg depottabletter Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

viclonor 75 mg depottabletter

nordic prime aps - diclofenacnatrium - depottabletter - 75 mg

Diclofenacnatrium "Paranova" 100 mg depottabletter Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

diclofenacnatrium "paranova" 100 mg depottabletter

paranova danmark a/s - diclofenacnatrium - depottabletter - 100 mg

Diclon 50 mg enterotabletter Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

diclon 50 mg enterotabletter

2care4 aps - diclofenacnatrium - enterotabletter - 50 mg

Axiumopto 1 mg/ml øjendråber, opløsning, enkeltdosisbeholder Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

axiumopto 1 mg/ml øjendråber, opløsning, enkeltdosisbeholder

uni-pharma kleon - dexamethasonnatriumphosphat - øjendråber, opløsning, enkeltdosisbeholder - 1 mg/ml

Clobex 500 mikrogram/g shampoo Danska - danski - Lægemiddelstyrelsen (Danish Medicines Agency)

clobex 500 mikrogram/g shampoo

paranova danmark a/s - clobetasolpropionat - shampoo - 500 mikrogram/g